top of page

Acerca de



9.30-9.35          Welcome & introduction (H.L.A. Janssen)


NASH (Chair tbc)

09.35-9.50         NASH & Fibrosis screening in the population based setting – Willem Pieter Brouwer

9.50-10.10        Holistic approach for the treatment of patients with NASH – Liesbeth van Rossum

10.10-10.20       Interactive table discussion


State of the Art Lecture

10.20-10.50       Acute kidney injury & fluid/salt balances in liver disease - Ewout Hoorn


10.50-11.20       Break


Liver Transplantation (Chair tbc)

11.20-11.35       Referral for liver transplantation with a low MELD score? – Caroline den Hoed

11.35-11.55       Working around the MELD: Living-related donation liver transplantation – Robert Porte

11.55-12.20       Graft preservation and regenerative medicine – Vincent de Meijer

12.20-12.30       Interactive table discussion


12.30-13.30       Lunch


State of the Art

13.30-13.35       Solko W. Schalm Award Ceremony

13.35-14.05       HBV/HDV: present and future – Heiner Wedemeyer  


Liver tumors (Chair tbc)

14.05-14.20       How to optimize HCC surveillance in chronic HBV infection – yes or no? – Milan Sonneveld

14.20-14.45       TIPS before advanced therapies for HCC – Dominique Thabut

14.45-15.10       New treatment schemes for HCC: From immunotherapy to Yttrium – Maria Reig

15.10-15.20       Interactive table discussion        


State of the Art 

15.20-15.50       Difficult to treat AIH – Treatment roadmap, off-label therapies and response criteria - Christoph Schramm


15.50-16.00       Closing remarks – Harry Janssen

16.35                Drinks

bottom of page